Recent advances in nanoparticle applications in respiratory disorders: a review

ME Taghavizadeh Yazdi, M Qayoomian… - Frontiers in …, 2023 - frontiersin.org
Various nanoparticles are used in the discovery of new nanomedicine to overcome the
shortages of conventional drugs. Therefore, this article presents a comprehensive and up-to …

The pharmacological efficacy of baicalin in inflammatory diseases

Y Wen, Y Wang, C Zhao, B Zhao, J Wang - International Journal of …, 2023 - mdpi.com
Baicalin is one of the most abundant flavonoids found in the dried roots of Scutellaria
baicalensis Georgi (SBG) belonging to the genus Scutellaria. While baicalin is demonstrated …

H3K18 lactylation promotes the progression of arsenite-related idiopathic pulmonary fibrosis via YTHDF1/m6A/NREP

P Wang, D Xie, T Xiao, C Cheng, D Wang, J Sun… - Journal of Hazardous …, 2024 - Elsevier
As epigenetic modifications, lactylation and N6-methyladenosine (m6A) have attracted wide
attention. Arsenite is an environmental pollutant that has been proven to induce idiopathic …

Targeting growth factor and cytokine pathways to treat idiopathic pulmonary fibrosis

H Ma, S Liu, S Li, Y Xia - Frontiers in Pharmacology, 2022 - frontiersin.org
Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease of unknown origin
that usually results in death from secondary respiratory failure within 2–5 years of diagnosis …

Antifibrotic effects of sodium-glucose cotransporter-2 inhibitors: A comprehensive review

N Shakour, S Karami, M Iranshahi, AE Butler… - Diabetes & Metabolic …, 2023 - Elsevier
Background and aims Scar tissue accumulation in organs is the underlying cause of many
fibrotic diseases. Due to the extensive array of organs affected, the long-term nature of …

[HTML][HTML] Aerosol pulmonary immune engineering

ER Sudduth, M Trautmann-Rodriguez, N Gill… - Advanced Drug Delivery …, 2023 - Elsevier
Aerosolization of immunotherapies poses incredible potential for manipulating the local
mucosal-specific microenvironment, engaging specialized pulmonary cellular defenders …

Increased expression of OPN contributes to idiopathic pulmonary fibrosis and indicates a poor prognosis

J Ji, S Zheng, Y Liu, T Xie, X Zhu, Y Nie, Y Shen… - Journal of Translational …, 2023 - Springer
Background Idiopathic pulmonary fibrosis (IPF) is fibrotic lung disease with no effective
treatment. It is characterized by destruction of alveolar structure and pulmonary interstitial …

Progress in understanding and treating idiopathic pulmonary fibrosis: Recent insights and emerging therapies

H Guo, J Sun, S Zhang, Y Nie, S Zhou… - Frontiers in …, 2023 - frontiersin.org
Idiopathic pulmonary fibrosis (IPF) is a long-lasting, continuously advancing, and irrevocable
interstitial lung disorder with an obscure origin and inadequately comprehended …

Keloid disorder: genetic basis, gene expression profiles, and immunological modulation of the fibrotic processes in the skin

AJ Cohen, N Nikbakht, J Uitto - Cold Spring Harbor …, 2023 - cshperspectives.cshlp.org
Keloid disorder, a group of fibroproliferative skin disorders, is clinically comprised of keloids,
hypertrophic scars, keloidalis nuchae, and acne keloidalis. The prototype of these disorders …

Mitochondrial dysfunction in lung resident mesenchymal stem cells from idiopathic pulmonary fibrosis patients

J Mercader-Barceló, A Martín-Medina, J Truyols-Vives… - Cells, 2023 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is characterized by an aberrant repair response with
uncontrolled turnover of extracellular matrix involving mesenchymal cell phenotypes, where …